Stage 1, 2, and 3: what type 1 diabetes staging means
Type 1 diabetes often begins before thirst, weight loss, or high glucose ever shows up.
Updated August 2026 · 4 min read
The 30-second version
- Stage 1: autoantibodies present, normal glucose, no symptoms. Stage 2: autoantibodies plus abnormal glucose, still no symptoms. Stage 3: clinical diagnosis
- A single positive autoantibody is not the same as Stage 1. Results need confirmation and interpretation by a screening or diabetes team
- Stage 2 can create eligibility for teplizumab (Tzield), which delays progression to Stage 3 in eligible patients
- Screening is the only way to find out whether Tzield applies to you or your child
Type 1 diabetes often begins before thirst, weight loss, frequent urination, or high glucose appears. Screening looks for islet autoantibodies, markers that the immune system is attacking insulin-producing beta cells.
The stages
- Stage 1: Two or more persistent islet autoantibodies are present, but glucose stays in the normal range and there are no symptoms.
- Stage 2: Two or more autoantibodies are present and glucose regulation has become abnormal, but the person doesn't yet meet the usual clinical definition of symptomatic diabetes.
- Stage 3: Glucose criteria for diabetes are met, often with symptoms. Insulin treatment is required.
Some clinical frameworks also describe Stage 4 as established type 1 diabetes after diagnosis.
A single positive autoantibody isn't the same as Stage 1. Results should be confirmed and interpreted through a qualified screening or diabetes team. The type of antibody, age, persistence, number of antibodies, metabolic testing, and symptoms all affect risk and follow-up.
Why finding it earlier matters
Early detection creates time for education, monitoring, a sick-day plan, insurance preparation, school planning, and recognizing symptoms before a crisis. Structured monitoring programs have reported meaningfully lower DKA rates at diagnosis compared to the general population, though the exact reduction depends on the program and population, so no program can promise it eliminates DKA entirely.
Stage 2 may also create eligibility for teplizumab (Tzield), an FDA-approved treatment for adults and children age 8 and older that delays progression to Stage 3 in eligible patients. It doesn't prevent type 1 diabetes in a guaranteed percentage of people, and it isn't a cure.
What a screening test can and can't say
A negative test lowers concern at that moment but may not guarantee lifelong absence of risk, especially in children who may seroconvert later. A positive result isn't a prediction of the exact diagnosis date. It's a reason for confirmation, risk staging, and a monitoring plan.
Use the Glucopath screening finder to locate programs, then confirm eligibility, cost, specimen method, and follow-up with the program itself.
Sources
- ADA Standards of Care
- Breakthrough T1D, early detection
- FDA, Tzield approval
- TrialNet
Reading is the second step. Finding out what you qualify for is the first.
Keep reading
Your child screened positive. What happens next?
A positive screen can feel like a diagnosis and a warning at the same time. It is not. The next step is confirmation and a written plan.
You do not need a family history to get screened
Most people diagnosed with type 1 diabetes do not have a first-degree relative with the condition.
Glucopath is not medical or legal advice. Program rules change. Verify details with the program before you apply, and talk to your healthcare provider about your treatment.